SCHEMBL22905461

SCHEMBL22905461

O=Cc1c(O)cccc1OCc1cccnc1N1CCCC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 4/20 0.54
CYP1A2 P05177 3/20 0.54
CYP2C9 P11712 3/20 0.54
CYP3A4 P08684 2/20 0.54
CYP2C8 P10632 1/20 0.54
KDM4E B2RXH2 3/20 0.37
FAAH O00519 1/20 0.36
SCN10A Q9Y5Y9 3/20 0.36
ERN1 O75460 2/20 0.36
ALDH1A1 P00352 2/20 0.35
PIM1 P11309 1/20 0.35
P2RX7 Q99572 2/20 0.35
HIF1A Q16665 1/20 0.35
TSHR P16473 2/20 0.35
LMNA P02545 1/20 0.35
TP53 P04637 1/20 0.35
ALOX15 P16050 1/20 0.35
MAPK1 P28482 1/20 0.35
SCN2A Q99250 2/20 0.35
POLB P06746 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16080787 0.99 CYP2C19 (0.53) CYP2C19CYP1A2CYP2C9CYP3A4CYP2C8
SCHEMBL29512280 0.91 CYP1A2 (0.51) CYP2C19CYP1A2CYP2C9CYP3A4CYP2C8
SCHEMBL16100684 0.91 CYP1A2 (0.51) CYP2C19CYP1A2CYP2C9CYP3A4CYP2C8
SCHEMBL16094326 0.90 CYP1A2 (0.54) CYP2C19CYP1A2CYP2C9CYP3A4CYP2C8
SCHEMBL16095478 0.90 CYP1A2 (0.54) CYP2C19CYP1A2CYP2C9CYP3A4CYP2C8
SCHEMBL16080786 0.86 CYP1A2 (0.42) CYP2C19CYP1A2CYP2C9CYP3A4CYP2C8
SCHEMBL16080792 0.85 CYP1A2 (0.42) CYP2C19CYP1A2CYP2C9CYP3A4CYP2C8
SCHEMBL16119766 0.85 CYP1A2 (0.49) CYP2C19CYP1A2CYP2C9CYP3A4CYP2C8
SCHEMBL16033977 0.85 CYP1A2 (0.49) CYP2C19CYP1A2CYP2C9CYP3A4CYP2C8
SCHEMBL16034915 0.85 CYP1A2 (0.49) CYP2C19CYP1A2CYP2C9CYP3A4CYP2C8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2968299-B1 COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN GLOBAL BLOOD THERAPEUTICS INC (US) 2021-01-20 EP disclosed